HI
NEO icon

Hudock Inc’s NeoGenomics NEO Stock Holding History

Hudock Inc’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-14
Closed – – 756
2020
Q1 		$0 Sell
14
-251
-95% -$7.52K ﹤0.01% 719
2019
Q4 		$7K Buy
+265
New +$6.31K ﹤0.01% 454

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
KFO
Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hudock Inc's NEO Position: Q2 2020 in Review

Hudock Inc sold out of NeoGenomics (NEO) in Q2 2020, closing a stake of 14 shares.

Hudock Inc first reported a position in NEO in Q4 2019 and held it in 2 quarters. The position peaked at $7K in Q4 2019. 285 funds tracked by Wall St. Rank hold NEO as of Q2 2020.

  • Hudock Inc reported no remaining NeoGenomics position as of Q2 2020 after selling out during the quarter.
  • Hudock Inc sold 14 NeoGenomics shares in Q2 2020.
  • Hudock Inc first reported a position in NeoGenomics in Q4 2019 and held it in 2 quarters.
  • Hudock Inc's NeoGenomics position peaked at $7K in Q4 2019.
  • 285 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2020.

Based on Hudock Inc's 13F filing for Q2 2020, filed 11 Aug 2020.